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Basic Investigations 
Preliminary Study on the Mechanism of Acupoint Injection of Bone 
Marrow Mesenchymal Stem Cells in Improving Blood Flow in the Rat of 
Hind Limb Ischemia 
ZHU Chao-jun ᴅᳱݯ 1,3, DONG Jian-xun 㨷ᓎ࢟ 1, LI Jianᴢع 2, ZHANG Mei-ji ᓴ㕢ঢ় 2,  
WANG Le-ping ⥟Фᑇ 2, and LUO Ling 㔫⦆ 2 
Objective: To explore the mechanism of acupoint injection of bone marrow mesenchymal stem cells (BM-MSCs) 
in improving blood flow in the rat with hind limb ischemia.  
Methods: Twenty-four SD rats were randomly divided into 4 groups: normal control group (n=6), model group 
(n=6), BM-MSCs acupoint injection group (AI group, n=6) and BM-MSC intramuscular injection group (MI group, 
n=6). Sanyinjiao (SP 6), Housanli (ST 36), Zhaohai (KI 6), Huantiao (GB 30) and Yanglingquan (GB 34) were 
selected for the AI group, and five non-acupoints were selected on gastrocnemius and adductor of ischemic hind 
limbs in the MI group. BM-MSCs were injected to the latter two groups. The rat hind limb ischemia model was 
established with the method of blocking the femoral artery and its branches. Three weeks after injection of 
BM-MSCs, in each group, hindlimb adductor and gastrocnemius were taken from the ischemic side. Expressions of 
vascular endothelial growth factor (VEGF) and transfer growth factor-ȕ1 (TGF-ȕ1) in the skeletal muscle were 
determined with immunohistochemical method, and the small arteries in the skeletal muscle were labeled with 
Į-SMA immunohistochemical staining method, the density of small arteries (number of arterioles / number of muscle 
fibers) and the number of the blood vessel with VEGF positive expression were calculated. The serum levels of 
VEGF and nitric oxide (NO) were detected.
Results: Compared with the model group, the expression of VEGF and TGF-ȕ1, and the density of small arteries 
and the number of VEGF-positive blood vessels in the AI group and theMI group significantly increased (both 
P<0.01). Compared with the MI group, the density of small arteries and the number of VEGF-positive blood vessels 
in the AI group significantly increased (both P<0.01); Compared with the model group and the normal control 
group, the serum expression quantity ofNO and VEGF in the AI group and the MI group were significantly 
increased (P<0.01).
Conclusions: Acuppoint injection of BM-MSCs secrets more VEGF, TGF-ȕ1 and NO to increase angiogenesis and 
arteriogenesis, so as to improve blood flow of the rats of hind limb ischemic. 
Keywords: Acupoint injection; Bone marrow mesenchymal stem cells (BM-MSCs); Ischemia; VEGF; TGF-ȕ1; NO 
After arterial occlusion, sprouting new capillaries sprout 
(i.e. angiogenesis) and growing and remodeling the 
preexisting arterioles grow and remodel into 
physiologically relevant arteries (i.e. arteriogenesis).1 In 
the process of angiogenesis and arteriogenesis, vascular 
endothelial growth factor (VEGF) and transfer growth 
factor-ȕ1 (TGF-ȕ1 ) play an important role.2 In addition, a 
large number of evidences indicate that an effective  
angiogenesis requires participation of endogenous nitric 
oxide (NO),3 and it has been confirmed that endothelial 
nitric oxide synthase( eNOS) and NO are necessary for 
the restoration of blood flow and formation of new blood 
vessels after ischemia.4
Previous studies showed that acupoint injection of bone 
marrow mesenchymal stem cells (BM-MSCs) could 
significantly improve perfusion in the rats of hind limb 
ischemic.5 In this paper, expressions of VEGF and 
TGF-ȕ1 in the skeletal muscle, and serum levels of 
VEGF and NO were determined, and the density of small 
arteries (number of arterioles/ number of muscle fibers) 
and number of the blood vessel with VEGF positive 
expression were calculated. The serum levels of VEGF 
and NO were detected after acupoint injection of 
BM-MSCs in the hind limb ischemia model rat, so as to 
explore the mechanism of acupoint injection of 
BM-MSCs in improvement of blood flow.1
MATERIALS AND METHODS 
Rat Bone Marrow Mesenchymal Stem Cells 
SD rat BM-MSCs and the complete culture fluid 
BM-MSCs were both purchased from Cyagen 
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Biosciences (Guangzhou) Inc.
Laboratory Animals 
Twenty-four SD rats (SPF), body weight (200±20) g, 
either sex, were purchased from Beijing Weitong Lihua 
Company (Animal Certificate No.: SCXX (Jing) 
2007-0001). 
Main Experimental Instruments and Main Reagents 
Cell incubator:MC0175CO cell incubator (SANYO 
Corporation), OLYMPUSix-71 inverted microscope 
(OLYMPUS), Nikon C-SHG1 image analysis system 
(Nikon), Automatic enzyme immunoassay instrument 
(U.S. awareness technology products), radioimmun- 
oassay instrument (China).  
NO kit was purchased from Nanjing Jiancheng 
Bio-Engineering Institute; VEGF and TGF-ȕ1 kits were 
purchased from Beijing Bo Ao Sen ( म ༹ Ể ) 
Biotechnology Co., Ltd. Į-SMA primary antibody was 
purchased by Abcam Company, USA.  
Experimental Animals and Grouping 
Twenty-four healthy SD rats were adaptively fed for 3 
days and then were randomly divided into four groups, 6 
in each group: normal control group, model group, 
BM-MSCs acupoint injection group (AI group), and 
BM-MSCs muscular injection group (MI group). They 
freely access to food and water and were raised under the 
same conditions. 
Preparation of Animal Model  
Referring to the method in the literature,6 under aseptic 
condition, the rats were fixed at dorsal position on a rat 
plate after anesthesia (intraperitoneal injection of 10% 
chloral hydrate at the dose of 3.5 mL/kg). After vertically 
cutting from the left inguinal ligament to the knee joint, 
the femoral artery and its branches were isolated and 
ligated at both place near to the left common iliac artery 
and the popliteal artery using 5–0 suture silk, and then 
they were cut off at the middle of the both ligatures, thus 
establishing the ischemic hind limb model. Then the
subcutaneous tissue and skin were sutured, without 
anti-infection conducted after surgery.
Treatment Methods 
The 5 acupoints, Sanyinjiao (SP 6), Housanli (ST 36), 
Zhaohai (KI 6), Huantiao (GB 30), and Yanglingquan 
(GB 34) in the affected limb (the left side) were selected 
for the AI group, with the acupoints located according to 
the rat acupoint atlas of Hua, et al.7 While 5 non- 
acupoints on the medial part of the thigh of the left 
ischemic hind limbs were selected in the model group. 
After surgery, BM-MSCs were injected immediately into 
0.5–1.0 cm in depth. 5×106 BM-MSCs were injected to 
the rats in both the AI and the MI groups only once. 
Equal volume of phosphate buffer solution was injected 
into the same points in the model group as those in the 
MI group. No treatment was given to the right hind limbs 
of the rats in the AI, MI, and model groups, and they 
were taken as the normal control. No treatment was 
given to the rats in the normal control group. 
Determination of Serum NO and VEGF  
The rats were killed (spine dislocation) 3 weeks after the 
acupoint injection, and the blood was taken from the 
abdominal aorta. After standing for 30 min, the blood 
was centrifuged (1500 r/min, 15 min) and the supernatant 
was collected. According to the manual of NO and 
VEGF kits, serum contents of NO and VEGF were 
determined. 
Detection of VEGF, TGF-ȕ1 and TNF-Į Expression  
After blood flow measurement, 4 pieces of ischemic 
tissue from the adductor and gastrocnemius muscles 
were taken and put into 4% paraformaldehyde stationary 
liquid. After paraffin imbedding, they were cut into 
paraffin sections with 5 ȝm in thickness. The protein 
expression of TGF-ȕ1 and VEGF were analyzed with 
immunohistochemical method according to the manual 
of kids. Under the microscope, brown particles in the 
cytoplasm were considered as positive expression. Nikon 
image analysis system used to analysis the results of 
immunohistochemical expression. Five high power fields 
(40×) of each section were randomly selected for 
analysis of VEGF and TGF-ȕ1 expression. The positive 
expression area multiplied the average optical density 
(MOD) were calculated. 
Measurements of the Density of Į-SMA Labeled 
Small Arteries and VEGF-positive Capillaries  
Twenty-one days after acupoint injection of BM-MSCs, 
the rats were anaesthetized and the adductor and 
gastrocnemius muscle of the hind limb were taken and 
fixed with formaldehyde, and then the transverse section 
of the muscle with 5 ȝm in thickness were made. When 
anti-smooth muscle actin immunohistochemical staining 
is used to label the smooth muscle of vascular wall, the 
part of Į-SMA positive expression is considered to be 
location of the small arteries. Nikon C-SHG1 image 
analysis system was used, and 10 field of vision were 
selected under the high-power microscope (10×40), the 
density of small arteries (number of small arteries in the 
microscope / muscle bundles) was calculated . 
The sections were stained with the manual of VEGF 
immunohistochemical kit, the cells with brown-yellow 
granules were regarded as positive cells, namely VEGF 
positive expression capillaries. Ten fields of vision were 
randomly selected under the high-power microscope 
(10×40) and the number of the VEGF positive expression  
capillary was counted, and the average number was 
calculated in each group.  
Statistical Analysis 
All the data were expressed as sx ±  and processed 
with SPSS11.0 software. Comparisons of parameters 
among the four groups were made by one way ANOVA 
followed by Scheffe’s multiple comparison test. A 
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probability value <0.05 was considered statistically 
significant. 
RESULTS 
Comparison of VEGF and TGF-ȕ1 Expressions in the 
4 Groups 
Compared with the normal control and model groups, the 
protein expression of VEGF and TGF-ȕ1 in both the AI 
and the MI groups were increased significantly (P<0.01). 
Compared with the MI group, the protein expression of 
VEGF and TGF-ȕ1 in the AI group were increased 
significantly (P<0.01 or P<0.05, Table 1). 
Table 1. Comparison TGF-ȕ1 and VEGF expressions  
in the 4 groups˄ sx ± ˅
Group         n TGF-ȕ1 VEGF 
normal control  6 11.67±1.98 6.29±0.80 
Model        6 11.99±4.89 12.89±2.88** 
MI           6 20.80±5.03**ŸŸ 17.94±2.09**ŸŸ
AI           6 25.63±3.23**ŸŸƸ 26.57±4.59**ŸŸƸƸ
Notes: **P<0.01 vs the normal control group; ŸŸ P<0.01 vs the 
model group; ƸP<0.05, ƸƸ P<0.01 vs the MI group. 
Comparison of Serum Contents of NO and VEGF 
among the 4 Groups 
Compared with the normal control and model groups, the 
serum contents of NO and VEGF in the MI and AI 
groups were increased significantly (P<0.01). Compared 
with the MI group, the contents of NO and VEGF in the 
AI group did not have significant difference (P>0.05, 
Table 2). 
Table 2. Comparison of serum VEGF and NO contents 
among the four groups˄ sx ± , n=6˅
Group NO (μmol/L) VEGF (ng/mL) 
normal control  25.64±3.93 47.91±6.86 
Model  27.69±3.77 55.21±11.05 
MI 35.48±5.56**ƸƸ 83.09±23.34**ͪ
AI 38.41±5.48**ƸƸ 85.67±29.67**ͪ
Notes:**P<0.01 vs the normal group ;ƸƸP<0.01 ,
ƸP< 0.05 vs the model group. 
Comparison of VEGF-positive Capillaries and 
Density of Small Arteries among the 4 Groups
Compared with the normal control and model group, the 
VEGF-positive capillaries and the density of small 
arteries in AI and MI groups are increased significantly 
(P<0.01). Compared with the MI group, VEGF-positive 
capillaries and the density of small arteries in AI group 
was increased significantly (P<0.01, Table 3, Figure 1, 
and Figure 2). 
Table 3. VEGF-positive capillaries and the density of 
small arteries among the 4 group˄ sx ± , n=6˅




normal control 0.85±0.06 9.38±1.19 
Model  0.90±0.09 10.50±1.20 
MI 1.40±0.11ˆˆŸŸ 17.00±2.62ˆˆŸŸ
AI 1.80±0.07 ˆˆŸŸƸƸ 19.875±2.5ˆˆŸŸƸƸ
 Notes: ˆˆP<0.01 vs the normal control group; ŸŸ P<0.01 vs the 
model group; ƸƸ P<0.01 vs the MI group. 
                        
Figure 1. Anti-Į-SMA-labeled small arteries (×400)            Figure 2. VEGF-positive capillaries (×400)
The arrow indicates capillaries                                       The arrow indicates small arteries  
Notes: Histologic sections of muscle tissues in which bone marrow mesenchymal stem cells (BM-MSCs) were implanted. Sections 
were stained with immunohistochemical staining method. Figure1.Section was stained with anti Į-SMA antibodies.(Antibody was 
diluted to 1:200). Figure 2.Section was stained with anti VEGF antibodies.(Antibody was diluted to 1:200).
DISCUSSION 
There are 2 mechanisms for vascular growth in adults 
after embryogenesis: 1) Angiogenesis, proliferation of 
local capillaries increases local blood perfusion; 2) 
arteriogenesis, dilation of preexisting high resistance 
collateral blood vessels decreases flow resistance to 
increase blood perfusion in the ischemic region.8
BM-MSCs are effective in augmenting the vascular 
response to arterial occlusion, increasing capillary counts 
and collateral blood flow in the hindlimb. In addition, 
BM-MSCs have been shown to form capillary-like 
structures in an in vitro Matrigel assay. Furthermore, 
MSC transplantation has been shown to induce 
angiogenesis in a rat model of hindlimb ischemia.9
BM-MSCs in the bone marrow stroma differentiate into 
osteoblasts, chondrocytes, neurons, skeletal muscle cells, 
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endothelial progenitor cells and vascular smooth muscle 
cells. There exist three mechanisms by which endothelial 
progenitor cells can enhance collateral development. 1) 
Support: Progenitor cells secrete multiple cytokines, 
growth factors, and chemokines that can facilitate 
arteriogenesis by a) influencing the matrix in a way  
conducive for collateral development, b) inhibiting
endothelial and smooth muscle cell apoptosis and 
stimulating their migration and proliferation, and c) 
recruiting proarteriogenic inflammatory and progenitor 
cells. 2) Incorporation: Progenitor cells could directly 
incorporate into the developing collateral and thereby 
physically contribute to collateral formation; the 
biological importance of this mechanism is presently a 
source of controversy. 3) Fusion: Fusion of progenitor 
cells with tissue specific cells has been demonstrated, but 
no data indicate that this functionally contributes to 
collaterogenesis.8  
The results show that compared with the MI group, 
VEGF-positive capillaries and the density of small 
arteries in the AI group were increased significantly 
(P<0.01). It is indicated that in the process of acupoint 
injection of bone marrow mesenchymal stem cells to 
improve blood flow in rat hind limb there exists not only 
angiogenesis but also arteriogenesis. Because the 
injected bone marrow mesenchymal stem cells were not 
labeled, so we can not determine it how to participate in 
angiogenesis and arteriogenesis. 
This study demonstrated that acupoint injection of 
BM-MSCs could significantly increase serum contents of 
NO and VEGF, and the expression of VEGF and 
TGF-ȕ1 in the ischemic skeletal muscle. In the MI group 
and the AI group the local injection method was adopted, 
so serum levels of VEGF and NO in the two groups did 
not have significant changes.  
VEGF, an important factor for promotion of blood vessel 
formation, plays an important role in angiogenesis. In 
addition, they regulate angiogenesis and vascular 
maintenance during embryogenesis and in adults.10
VEGF has been known as one of the key factors in 
angiogenesis and acts on several aspects of this process, 
including endothelial proliferation, migration, and tube 
formation. VEGF can enhance endothelial regeneration, 
restore endothelial function, and stimulate angiogenesis. 
TGF-ȕ is a polypeptide growth factor which plays an 
important role in tissue repair and angiogenesis. TGF-ȕ1 
is a major member of the TGF-ȕ family, and it is a key 
cytokines in regulation of normal cell growth and other 
functions. TGF-ȕ1 can inhibit apoptosis of the MSCs 
induced by serum deprivation and hypoxia,11 promote the 
proliferation of BM-MSCs and maintain its biological 
activity in long time.12 Therefore, TGF-ȕ1 secreted by 
BM-MSCs not only reduce the apoptosis of BM-MSCs 
but also promote its cell growth, in turn, the high 
survival BM-MSCs secrets more TGF-ȕ1, with a good 
mutual promoting role. 
NO plays a critical role in ischemia-induced 
angiogenesis. Thus, impairment of this metabolic 
pathway is related with the development of peripheral 
arterial occlusive disease. Studies have shown that: 1) 
NO levels are increased in the ischemic limb; 2) 
Pharmacological inhibition or gene disruption of eNOS 
decreases NO levels and inhibits ischemia-induced 
angiogenesis; 3) Exogenous NO restores ischemia- 
induced angiogenesis; Moreover, agonist-dependent NO 
release restores ischemia-induced angiogenesis in these 
pathological situations1.  
Research has shown that VEGF, TGF-ȕ1 stimulates the 
release of NO from cultured human umbilical venous 
endothelial cells and upregulates the expression of nitric 
oxide synthase.13 Whether VEGF and TGF-ȕ1, paracrine 
by BM-MSCs, stimulate the release of NO is not known 
yet. 
Thus, firstly, acupoint injection of BM-MSCs produces 
more VEGF, TGF-ȕ1 and NO to promote angiogenesis 
and arteriogenesis; secondly, produces more TGF-ȕ1
which not only reduces the apoptosis of BM-MSCs but 
also promotes its cell growth; lastly, promotes synapse 
extension through secretion of VEGF and plays a role in  
neural protection and neural newborn, so as to reduce the 
peripheral nerve injury produced by hypoxic-ischemic,14
thereby increasing blood flow of the ischemic hindlimb.  
In short, injection of BM-MSCs into acupoint produces 
more VEGF, TGF-ȕ1 and NO to play the role of 
angiogenesis and arteriogenesis.  
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